Author: Samuel Garcia del Blanco

Curapath & Certest Join Forces to Offer Next-Generation Lipid Nanoparticles (LNP) Formulations with Proprietary Excipients

VALENCIA & ZARAGOZA, SPAIN, 07 OCT 2024. Curapath, a leading innovator in the manufacturing of novel lipid and polymer excipients, nanoparticle formulations and innovative polymer conjugates, and Certest Biotech, a Spanish company focused on the development of new products with special emphasis in Drug Delivery with Lipid Nanoparticles (LNPs) and Active Pharmaceutical

READ MORE »